Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Another way to generate T cells?

D Metcalf

    Nature Medicine
    |January 1, 1997
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Production of colony-stimulating factors and IL-5 by organs from three types of mice with inflammatory disease due to loss of the suppressor of cytokine signaling-1.

    Journal of immunology (Baltimore, Md. : 1950)·2001
    Same author

    Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease.

    Immunology·2001
    Same author

    Functional analysis of Asb-1 using genetic modification in mice.

    Molecular and cellular biology·2001
    Same author

    The multi-organ origin of interleukin-5 in the mouse.

    Leukemia·2001
    Same author

    Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same journal

    Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

    Nature medicine·2026
    Same journal

    Immune aging biomarkers for clinical trials.

    Nature medicine·2026
    Same journal

    Lassa fever countermeasures gather pace.

    Nature medicine·2026
    Same journal

    Why high scores do not mean application readiness for health AI.

    Nature medicine·2026
    Same journal

    Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

    Nature medicine·2026
    Same journal

    Biological aging might help to explain the rising risk of early-onset cancer.

    Nature medicine·2026
    See all related articles